Supply Chain

The FDA approved a non-opioid painkiller patch for nerve pain associated with shingles Feb. 28, according to Reuters.

The FDA approved expanded use for Eli Lilly's treatment for advanced or metastatic breast cancer Feb. 26.

Deerfield, Ill.-based Walgreens Boots Alliance and AmerisourceBergen have reportedly ended acquisition discussions without an agreement, sources familiar with the matter told CNBC.

When I started this “Champions of Change” series, I wrote about the importance of bringing diverse teams together and tapping into their strengths and knowledge. Being a Champion of Change isn’t just about your own great ideas — it’s also…

As part of a plan to reduce its $32.5 billion debt burden, Teva Pharmaceuticals closed offices in New York City and Washington D.C., according to The Calcalist.

Immense financial pressures, like declining reimbursements and a shift from inpatient to outpatient services, are forcing hospitals and health systems to accelerate efforts around driving cost efficiencies.

Here are the three latest drugs or medical devices approved by the FDA this week.

Amazon discretely launched Basic Care, an exclusive line of 60 over-the-counter healthcare products, last August and consumers are finding the products to be priced comparably, if not cheaper, to generic products retailed at other well-known pharmacies, according to Business Insider.

Achillion Pharmaceuticals, a clinical stage drugmaker based in New Haven, Conn., will slash its workforce by 20 percent to help offset an $85.2 million loss in fiscal year 2017.

As disruptors continue to push into the healthcare arena and pressure accumulates to reduce drug prices, pharmaceutical companies are taking steps to remain competitive and enhance their drug pipelines.